|
|
|
LifeScienceHistory.com - Check us out on Instagram
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Summit Therapeutics Inc.
| | | Year Established: | 2003 | Ticker: | SMMT | Exchange: | NASDAQ | Main Contact: | David Roblin, President, COO & CMO | | Other Contacts: | Glyn Edwards, CEO Erik Ostrowski, CFO
| | Company Description | Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease Duchenne muscular dystrophy and the infectious disease C. Difficile infection. | |
|
|
|
|
|